- Home
- CERO vs EVTV Comparison
CERO vs EVTV Comparison
Compare CERO & EVTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CERO
- EVTV
- Stock Information
- Founded
- CERO 2017
- EVTV 2012
- Country
- CERO United States
- EVTV United States
- Employees
- CERO N/A
- EVTV N/A
- Industry
- CERO
- EVTV Auto Manufacturing
- Sector
- CERO
- EVTV Consumer Discretionary
- Exchange
- CERO Nasdaq
- EVTV Nasdaq
- Market Cap
- CERO 3.5M
- EVTV 5.1M
- IPO Year
- CERO N/A
- EVTV 2017
- Fundamental
- Price
- CERO $9.40
- EVTV $0.18
- Analyst Decision
- CERO Strong Buy
- EVTV
- Analyst Count
- CERO 2
- EVTV 0
- Target Price
- CERO $45.00
- EVTV N/A
- AVG Volume (30 Days)
- CERO 3.3M
- EVTV 1.7M
- Earning Date
- CERO 08-13-2025
- EVTV 08-13-2025
- Dividend Yield
- CERO N/A
- EVTV N/A
- EPS Growth
- CERO N/A
- EVTV N/A
- EPS
- CERO N/A
- EVTV N/A
- Revenue
- CERO N/A
- EVTV $1,650,137.00
- Revenue This Year
- CERO N/A
- EVTV N/A
- Revenue Next Year
- CERO N/A
- EVTV N/A
- P/E Ratio
- CERO N/A
- EVTV N/A
- Revenue Growth
- CERO N/A
- EVTV N/A
- 52 Week Low
- CERO $6.71
- EVTV $0.15
- 52 Week High
- CERO $895.40
- EVTV $2.61
- Technical
- Relative Strength Index (RSI)
- CERO 47.17
- EVTV 43.36
- Support Level
- CERO $9.10
- EVTV $0.16
- Resistance Level
- CERO $9.73
- EVTV $0.20
- Average True Range (ATR)
- CERO 2.73
- EVTV 0.02
- MACD
- CERO 0.08
- EVTV 0.00
- Stochastic Oscillator
- CERO 12.57
- EVTV 46.67
About CERO CERo Therapeutics Holdings Inc. Common Stock
CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy. Its lead molecule is CER-1236, an autologous T-cell product that targets a novel tumor antigen, TIM-4 ligand.
About EVTV Envirotech Vehicles Inc.
Envirotech Vehicles Inc is a provider of purpose-built zero-emission electric vehicles focused on reducing the total cost of vehicle ownership and helping fleet operators unlock the benefits of green technology. It recognizes revenue from the sales of zero-emission electric vehicles and vehicle maintenance and inspection services. The Company serves commercial and last-mile fleets, school districts, public and private transportation service companies and colleges and universities to meet the increasing demand for light to heavy-duty electric vehicles.